ALNYLAM PHARMACEUTICALS, INC. Other Noncash Income (Expense)
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Other Noncash Income (Expense) of -$521.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2015-08-07
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2015-06-30 was -$274.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2015-03-31 was -$247.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2014-12-31 was -$179.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for the quarter ending 2014-09-30 was -$181.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2014 was -$692.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2013 was -$449.00K.
- ALNYLAM PHARMACEUTICALS, INC. other noncash income (expense) for fiscal 2012 was -$364.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2015-06-30 | -$274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$521.00K 10-Q · filed 2015-08-07 | -$700.00K derived: sum of 3 quarters · filed 2015-08-07 | -$881.00K derived: sum of 4 quarters · filed 2015-08-07 |
| 2015-03-31 | -$247.00K 10-Q · filed 2015-05-08 | -$426.00K derived: sum of 2 quarters · filed 2015-05-08 | -$607.00K derived: sum of 3 quarters · filed 2015-05-08 | -$782.00K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-12-31 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$360.00K derived: sum of 2 quarters · filed 2015-02-13 | -$535.00K derived: sum of 3 quarters · filed 2015-08-07 | -$692.00K 10-K · filed 2015-02-13 |
| 2014-09-30 | -$181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$356.00K derived: sum of 2 quarters · filed 2015-08-07 | -$513.00K 10-Q · filed 2014-11-06 | -$611.00K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-06-30 | -$175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$332.00K 10-Q · filed 2015-08-07 | -$430.00K derived: sum of 3 quarters · filed 2015-08-07 | -$534.00K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$157.00K 10-Q · filed 2015-05-08 | -$255.00K derived: sum of 2 quarters · filed 2015-05-08 | -$359.00K derived: sum of 3 quarters · filed 2015-05-08 | |
| 2013-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$202.00K derived: sum of 2 quarters · filed 2015-02-13 | -$449.00K 10-K · filed 2015-02-13 | |
| 2013-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$351.00K 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$247.00K 10-Q · filed 2014-08-08 | |||
| 2012-12-31 | -$364.00K 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |